Teleflex stock price target raised to $135 from $130 at RBC Capital
USANA Health Sciences Inc (NYSE:USNA). shares have reached a 52-week low, dipping to $23.63, as the company faces a tumultuous market environment. According to InvestingPro data, the company maintains impressive gross profit margins of 81% and holds more cash than debt on its balance sheet. This latest price point underscores a significant downturn for the nutritional and dietary supplements company, which has seen its stock value decrease by 44.62% over the past year. Investors are closely monitoring USANA’s performance, as the company navigates through the pressures of industry competition and shifting consumer trends that have impacted its market position and financial outlook. Trading at a P/E ratio of 10.8 and price-to-book of 0.85, InvestingPro analysis suggests the stock is currently undervalued, with 13 additional ProTips available for subscribers looking to make informed investment decisions.
In other recent news, USANA Health Sciences reported mixed results for its fiscal year 2024, with fourth-quarter earnings per share (EPS) of $0.64, surpassing analyst expectations of $0.49. The company’s revenue for the quarter reached $214 million, exceeding the forecasted $208.84 million. Despite this quarterly success, USANA’s full-year financials revealed a 7% decline in net sales to $855 million and a 34% drop in net earnings to $42.0 million compared to the previous year. The company also provided guidance for fiscal year 2025, forecasting earnings per share between $2.35 and $3.00, which fell short of the consensus estimate of $2.87. Revenue projections for FY2025 range from $920 to $1000 million, aligning closely with the consensus estimate of $934.5 million.
USANA recently completed the acquisition of Hiya Health, which is expected to contribute significantly to its revenue in 2025, with projections of $145 to $160 million. The company plans to launch over 20 new products and reformulations in 2025, aiming to strengthen its market presence. Analysts from Sidoti and Company and D.A. Davidson have expressed interest in USANA’s promotional strategies and the integration of Hiya Health. The company ended the year with $182 million in cash reserves and plans to increase this by $50 to $60 million in 2025.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.